{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:20:44Z","timestamp":1793395244061,"version":"4.5.0"},"reference-count":217,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["104771\/Z\/14\/Z"],"award-info":[{"award-number":["104771\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-StG-2015-637304"],"award-info":[{"award-number":["ERC-StG-2015-637304"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Both hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are a major global healthcare problem with more than 240 million and 70 million infected, respectively. Both viruses persist within the liver and result in progressive liver disease, resulting in liver fibrosis, cirrhosis and hepatocellular carcinoma. Strikingly, this pathogenesis is largely driven by immune responses, unable to clear an established infection, rather than by the viral pathogens themselves. Even though disease progression is very similar in both infections, HBV and HCV have evolved distinct mechanisms, by which they ensure persistence within the host. Whereas HCV utilizes a cloak-and-dagger approach, disguising itself as a lipid-like particle and immediately crippling essential pattern-recognition pathways, HBV has long been considered a \u201cstealth\u201d virus, due to the complete absence of innate immune responses during infection. Recent developments and access to improved model systems, however, revealed that even though it is among the smallest human-tropic viruses, HBV may, in addition to evading host responses, employ subtle immune evasion mechanisms directed at ensuring viral persistence in the absence of host responses. In this review, we compare the different strategies of both viruses to ensure viral persistence by actively interfering with viral recognition and innate immune responses.<\/jats:p>","DOI":"10.3390\/vaccines5030024","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T11:05:24Z","timestamp":1504263924000},"page":"24","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection"],"prefix":"10.3390","volume":"5","author":[{"given":"Ana","family":"Ortega-Prieto","sequence":"first","affiliation":[{"name":"Section of Virology, Department of Medicine, Imperial College London, London W2 1PG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Dorner","sequence":"additional","affiliation":[{"name":"Section of Virology, Department of Medicine, Imperial College London, London W2 1PG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H.L.A., Papatheodoridis, G., Zoulim, F., Tacke, F., and European Association for the Study of the Liver (2017). EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J. Hepatol.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13027-016-0099-0","article-title":"Hepatitis C virus (HCV) genotypes distribution: An epidemiological up-date in europe","volume":"11","author":"Petruzziello","year":"2016","journal-title":"Infect. Agent. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathol-012414-040323","article-title":"Hepatitis C virus-associated cancer","volume":"10","author":"Lin","year":"2015","journal-title":"Annu. Rev. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11894-014-0371-7","article-title":"Acute hepatitis C: Management in the rapidly evolving world of HCV","volume":"16","author":"Sharma","year":"2014","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.immunol.25.022106.141602","article-title":"Flying under the radar: The immunobiology of hepatitis C","volume":"25","author":"Dustin","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Jindal, A., Kumar, M., and Sarin, S.K. (2013). Management of acute hepatitis B and reactivation of hepatitis B. Liver Int.","DOI":"10.1111\/liv.12081"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis","volume":"1","author":"Guidotti","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/hep.22898","article-title":"The natural history of chronic hepatitis B virus infection","volume":"49","author":"McMahon","year":"2009","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cld.2010.05.007","article-title":"Natural history of chronic hepatitis B","volume":"14","author":"McMahon","year":"2010","journal-title":"Clin. Liver Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-2006-939751","article-title":"Hepatitis B e antigen-negative chronic hepatitis B: Natural history and treatment","volume":"26","author":"Hadziyannis","year":"2006","journal-title":"Semin. Liver Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12929-015-0199-y","article-title":"Natural history of chronic hepatitis B virus infection from infancy to adult life\u2014The mechanism of inflammation triggering and long-term impacts","volume":"22","author":"Wu","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/rmv.1779","article-title":"Inhibitory receptor molecules in chronic hepatitis B and C infections: Novel targets for immunotherapy?","volume":"24","author":"Hakim","year":"2014","journal-title":"Rev. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev-virology-100114-055249","article-title":"No love lost between viruses and interferons","volume":"2","author":"Fensterl","year":"2015","journal-title":"Annu. Rev. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Snell, L.M., McGaha, T.L., and Brooks, D.G. (2017). Type I interferon in chronic virus infection and cancer. Trends Immunol.","DOI":"10.1016\/j.it.2017.05.005"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-lambda: Immune functions at barrier surfaces and beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.coviro.2014.03.006","article-title":"Interferon-stimulated genes: Roles in viral pathogenesis","volume":"6","author":"Schoggins","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jhep.2013.07.033","article-title":"Interferon-stimulated genes and their role in controlling hepatitis C virus","volume":"59","author":"Metz","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Shu, Q., Lennemann, N.J., Sarkar, S.N., Sadovsky, Y., and Coyne, C.B. (2015). Adap2 is an interferon stimulated gene that restricts RNA virus entry. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005150"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/j.febslet.2013.07.055","article-title":"Concerted action of activation-induced cytidine deaminase and uracil-DNA glycosylase reduces covalently closed circular DNA of duck hepatitis B virus","volume":"587","author":"Chowdhury","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Luo, X., Huang, Y., Chen, Y., Tu, Z., Hu, J., Tavis, J.E., Huang, A., and Hu, Y. (2016). Association of hepatitis B virus covalently closed circular DNA and human APOBEC3b in hepatitis B virus-related hepatocellular carcinoma. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157708"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jmb.2010.05.029","article-title":"APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo","volume":"400","author":"Renard","year":"2010","journal-title":"J. Mol. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1742-4690-6-96","article-title":"Human APOBEC1 cytidine deaminase edits HBV DNA","volume":"6","author":"Gonzalez","year":"2009","journal-title":"Retrovirology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1073\/pnas.0408223102","article-title":"Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo","volume":"102","author":"Suspene","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1873-3468.12058","article-title":"TGF-beta triggers HBV cccDNA degradation through AID-dependent deamination","volume":"590","author":"Qiao","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.virol.2017.07.035","article-title":"Molecular characterization of AID-mediated reduction of hepatitis B virus transcripts","volume":"510","author":"Que","year":"2017","journal-title":"Virology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1073\/pnas.1221921110","article-title":"RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase","volume":"110","author":"Liang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","article-title":"Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP","volume":"443","author":"Iwamoto","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1038\/srep07242","article-title":"Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms","volume":"4","author":"Chen","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/hep.27913","article-title":"Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation","volume":"62","author":"Anggakusuma","year":"2015","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2012.11.005","article-title":"Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol","volume":"38","author":"Liu","year":"2013","journal-title":"Immunity"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus","volume":"42","author":"Sato","year":"2015","journal-title":"Immunity"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.79.5.2689-2699.2005","article-title":"Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular rna helicase, RIG-I","volume":"79","author":"Sumpter","year":"2005","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2013.09.050","article-title":"5\u2032-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells","volume":"721","author":"Chen","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1128\/MCB.01368-10","article-title":"Ddx60, a dexd\/h box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling","volume":"31","author":"Miyashita","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.celrep.2015.04.047","article-title":"Ddx60 is involved in RIG-I-dependent and independent antiviral responses, and its function is attenuated by virus-induced EGFR activation","volume":"11","author":"Oshiumi","year":"2015","journal-title":"Cell Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.1128\/JVI.01297-15","article-title":"Ddx60l is an interferon-stimulated gene product restricting hepatitis C virus replication in cell culture","volume":"89","author":"Grunvogel","year":"2015","journal-title":"J. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.virusres.2009.01.007","article-title":"PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control","volume":"142","author":"Kang","year":"2009","journal-title":"Virus Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/JVI.02113-07","article-title":"Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus","volume":"82","author":"Jiang","year":"2008","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10059-011-1059-6","article-title":"PKR-dependent mechanisms of interferon-alpha for inhibiting hepatitis B virus replication","volume":"32","author":"Park","year":"2011","journal-title":"Mol. Cells"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/JVI.76.6.2617-2621.2002","article-title":"Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice","volume":"76","author":"Guidotti","year":"2002","journal-title":"J. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2893.2006.00732.x","article-title":"Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication","volume":"13","author":"Itsui","year":"2006","journal-title":"J. Viral. Hepat."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.1038\/srep09012","article-title":"Interferon-alpha inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection","volume":"5","author":"Meyer","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7150\/ijbs.5613","article-title":"Interferon induced IFIT family genes in host antiviral defense","volume":"9","author":"Zhou","year":"2013","journal-title":"Int. J. Biol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/hep.25908","article-title":"Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication","volume":"56","author":"Metz","year":"2012","journal-title":"Hepatology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"12881","DOI":"10.1128\/JVI.05633-11","article-title":"ISG56 and IFITM1 proteins inhibit hepatitis C virus replication","volume":"85","author":"Raychoudhuri","year":"2011","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hep.26066","article-title":"IFITM1 is a tight junction protein that inhibits hepatitis C virus entry","volume":"57","author":"Wilkins","year":"2013","journal-title":"Hepatology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000353220","article-title":"Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication","volume":"6","author":"Pei","year":"2014","journal-title":"J. Innate. Immun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1111\/j.1365-2893.2011.01452.x","article-title":"Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable stat1 cell line","volume":"18","author":"Yao","year":"2011","journal-title":"J. Viral. Hepat."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1128\/JVI.78.18.9713-9720.2004","article-title":"Regulation of hepatitis C virus replication by interferon regulatory factor 1","volume":"78","author":"Kanazawa","year":"2004","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhep.2012.08.007","article-title":"HCV NS5a and IRF9 compete for cypa binding","volume":"58","author":"Bobardt","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Liu, Y., Nie, H., Mao, R., Mitra, B., Cai, D., Yan, R., Guo, J.T., Block, T.M., Mechti, N., and Guo, H. (2017). Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006296"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"68179","DOI":"10.18632\/oncotarget.11907","article-title":"Interferon-stimulated gene of 20 kda protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo","volume":"7","author":"Leong","year":"2016","journal-title":"Oncotarget"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1099\/jgv.0.000607","article-title":"Hepatitis C virus replicative double-stranded RNA is a potent interferon inducer that triggers interferon production through MDA5","volume":"97","author":"Du","year":"2016","journal-title":"J. Gen. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/hep.25608","article-title":"Mxa inhibits hepatitis B virus replication by interaction with hepatitis B core antigen","volume":"56","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Shi, X., Jiao, B., Chen, Y., Li, S., and Chen, L. (2017). Mxa is a positive regulator of type I ifn signaling in HCV infection. J. Med. Virol.","DOI":"10.1002\/jmv.24867"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/JVI.00236-10","article-title":"Inhibition of hepatitis B virus replication by MYD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-s\/s RNAs","volume":"84","author":"Li","year":"2010","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0168-8278(03)00389-1","article-title":"The role of inducible nitric oxide synthase in a murine acute hepatitis B virus (HBV) infection model induced by hydrodynamics-based in vivo transfection of HBV-DNA","volume":"39","author":"Chang","year":"2003","journal-title":"J. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"8744","DOI":"10.1128\/JVI.74.18.8744-8750.2000","article-title":"Activation of the interferon-inducible 2\u2032-5\u2032-oligoadenylate synthetase gene by hepatitis C virus core protein","volume":"74","author":"Naganuma","year":"2000","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2010.01.034","article-title":"2\u2032,5\u2032-oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro","volume":"392","author":"Ishibashi","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2012.01.010","article-title":"Inhibition of hepatitis B virus replication by phospholipid scramblase 1 in vitro and in vivo","volume":"94","author":"Yang","year":"2012","journal-title":"Antiviral. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/febs.13563","article-title":"The cyclic GMP-AMP synthetase-sting signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly","volume":"283","author":"Dansako","year":"2016","journal-title":"FEBS J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1189\/jlb.2A1211-608RRRR","article-title":"Hepatitis C virus (HCV)-induced suppressor of cytokine signaling (SOCS) 3 regulates proinflammatory TNF-alpha responses","volume":"96","author":"Collins","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1128\/JVI.02484-09","article-title":"Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner","volume":"84","author":"Shao","year":"2010","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","article-title":"IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome","volume":"122","author":"Belloni","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/JVI.79.3.1569-1580.2005","article-title":"Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: Role of STAT-3 in HCV replication","volume":"79","author":"Waris","year":"2005","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"38336","DOI":"10.1038\/srep38336","article-title":"STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-lambda but not by interferon-alpha","volume":"6","author":"Yamauchi","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.1128\/JVI.00933-15","article-title":"The interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion","volume":"89","author":"Yan","year":"2015","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1566524013666131118111719","article-title":"Bst-2 expression in human hepatocytes is inducible by all three types of interferons and restricts production of hepatitis C virus","volume":"14","author":"Amet","year":"2014","journal-title":"Curr. Mol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2012.03.011","article-title":"Modulation of hepatitis C virus release by the interferon-induced protein BST-2\/tetherin","volume":"428","author":"Kuzmina","year":"2012","journal-title":"Virology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2009.06.020","article-title":"Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication","volume":"51","author":"Wang","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","article-title":"HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons","volume":"142","author":"Thomas","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"10421","DOI":"10.1128\/JVI.00996-14","article-title":"Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model","volume":"88","author":"Wu","year":"2014","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Negash, A.A., Ramos, H.J., Crochet, N., Lau, D.T., Doehle, B., Papic, N., Delker, D.A., Jo, J., Bertoletti, A., and Hagedorn, C.H. (2013). IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003330"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Lee, J., Tian, Y., Chan, S.T., Kim, J.Y., Cho, C., and Ou, J.H. (2015). TNF-alpha induced by hepatitis C virus via TLR7 and TLR8 in hepatocytes supports interferon signaling via an autocrine mechanism. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004937"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis B virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"32336","DOI":"10.1038\/srep32336","article-title":"TRIM14 inhibits hepatitis C virus infection by spry domain-dependent targeted degradation of the viral NS5a protein","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.23011","article-title":"Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located ring domain","volume":"50","author":"Gao","year":"2009","journal-title":"Hepatology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/cmi.2014.131","article-title":"Interferon alpha (IFNalpha)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5a","volume":"13","author":"Yang","year":"2016","journal-title":"Cell Mol. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Zhang, S., Guo, J.T., Wu, J.Z., and Yang, G. (2013). Identification and characterization of multiple TRIM proteins that inhibit hepatitis B virus transcription. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070001"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep.24542","article-title":"The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5a","volume":"54","author":"Helbig","year":"2011","journal-title":"Hepatology"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Mao, R., Nie, H., Cai, D., Zhang, J., Liu, H., Yan, R., Cuconati, A., Block, T.M., Guo, J.T., and Guo, H. (2013). Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003494"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12985-015-0245-0","article-title":"The efficacy of zinc finger antiviral protein against hepatitis B virus transcription and replication in tansgenic mouse model","volume":"12","author":"Chen","year":"2015","journal-title":"Virol. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jhep.2016.12.024","article-title":"Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B","volume":"66","author":"Lebosse","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jhep.2015.07.014","article-title":"Early inhibition of hepatocyte innate responses by hepatitis B virus","volume":"63","author":"Luangsay","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Cheng, X., Xia, Y., Serti, E., Block, P.D., Chung, M., Chayama, K., Rehermann, B., and Liang, T.J. (2017). Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages. Hepatology.","DOI":"10.1002\/hep.29348"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/JVI.75.6.2684-2691.2001","article-title":"Inhibition of hepatitis B virus replication by the interferon-inducible MXA protein","volume":"75","author":"Gordien","year":"2001","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/eri.13.37","article-title":"PEGIFN-alpha2a for the treatment of chronic hepatitis B and C: A 10-year history","volume":"11","author":"Degasperi","year":"2013","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/liv.12409","article-title":"A brief history of hepatitis milestones","volume":"34","author":"Trepo","year":"2014","journal-title":"Liver Int."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/hep.26182","article-title":"Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-lambda in response to hepatitis C virus","volume":"57","author":"Yoshio","year":"2013","journal-title":"Hepatology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"Il28b is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28b with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28b predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28b) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Muchmore","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nri3044","article-title":"NK cell development, homeostasis and function: Parallels with CD8(+) t cells","volume":"11","author":"Sun","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri3370","article-title":"Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution","volume":"13","author":"Parham","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1189\/jlb.1RU0514-241R","article-title":"Tissue-specific NK cell populations and their origin","volume":"96","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1089\/jir.2006.26.854","article-title":"Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons","volume":"26","author":"Larkin","year":"2006","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Yang, C.M., Yoon, J.C., Park, J.H., and Lee, J.M. (2017). Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175793"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.4049\/jimmunol.167.3.1566","article-title":"Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms","volume":"167","author":"Kafrouni","year":"2001","journal-title":"J. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"903764","DOI":"10.1155\/2014\/903764","article-title":"Natural killer cell function and dysfunction in hepatitis C virus infection","volume":"2014","author":"Holder","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.192.7.921","article-title":"Natural killer T cell activation inhibits hepatitis B virus replication in vivo","volume":"192","author":"Kakimi","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2013.00057","article-title":"NK cells: A double-edged sword in chronic hepatitis B virus infection","volume":"4","author":"Maini","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cei.12597","article-title":"Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection","volume":"180","author":"Zheng","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.179.5.1529","article-title":"T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6","volume":"179","author":"Mizuhara","year":"1994","journal-title":"J. Exp. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.77.7.4033-4042.2003","article-title":"Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid integrity through activation of NF-kappab","volume":"77","author":"Biermer","year":"2003","journal-title":"J. Virol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: What\u2019s in a name?","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2811","article-title":"Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity","volume":"18","author":"Zeissig","year":"2012","journal-title":"Nat. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2014.04.026","article-title":"The role of kupffer cells in hepatitis B and hepatitis C virus infections","volume":"61","author":"Boltjes","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.510270620","article-title":"Expression of co-stimulatory molecules by kupffer cells in chronic hepatitis of hepatitis C virus etiology","volume":"27","author":"Burgio","year":"1998","journal-title":"Hepatology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.24508","article-title":"Cross-presentation of antigen by diverse subsets of murine liver cells","volume":"54","author":"Ebrahimkhani","year":"2011","journal-title":"Hepatology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.4049\/jimmunol.1500839","article-title":"Kupffer cells support hepatitis B virus-mediated CD8+ T cell exhaustion via hepatitis b core antigen-TLR2 interactions in mice","volume":"195","author":"Li","year":"2015","journal-title":"J. Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/hep.21482","article-title":"Regulation of toll-like receptor-2 expression in chronic hepatitis B by the precore protein","volume":"45","author":"Visvanathan","year":"2007","journal-title":"Hepatology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1128\/JVI.03106-14","article-title":"Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7","volume":"89","author":"Jia","year":"2015","journal-title":"J. Virol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.4049\/jimmunol.1501881","article-title":"Hepatitis C virus-induced myeloid-derived suppressor cells suppress NK cell IFN-gamma production by altering cellular metabolism via arginase-1","volume":"196","author":"Goh","year":"2016","journal-title":"J. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3856","article-title":"Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells","volume":"21","author":"Pallett","year":"2015","journal-title":"Nat. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ni.1822","article-title":"Dendritic cell subsets in primary and secondary T cell responses at body surfaces","volume":"10","author":"Heath","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2741\/3279","article-title":"The divergence and interplay between PDC and MDC in humans","volume":"14","author":"Kadowaki","year":"2009","journal-title":"Front. Biosci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/eji.200738060","article-title":"Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells","volume":"38","author":"Schildberg","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/hep.25904","article-title":"Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection","volume":"56","author":"Velazquez","year":"2012","journal-title":"Hepatology"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1348-0421.2012.00496.x","article-title":"Hepatitis B virus surface antigen can activate human monocyte-derived dendritic cells by nuclear factor kappa b and p38 mitogen-activated protein kinase mediated signaling","volume":"56","author":"Jan","year":"2012","journal-title":"Microbiol. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jhep.2014.04.007","article-title":"Dendritic cell maturation in HCV infection: Altered regulation of MHC class I antigen processing-presenting machinery","volume":"61","author":"Leone","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2893.2007.00879.x","article-title":"Hepatitis C virus E2 envelope protein induces dendritic cell maturation","volume":"14","author":"Zhou","year":"2007","journal-title":"J. Viral. Hepat."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"10862","DOI":"10.1128\/JVI.77.20.10862-10871.2003","article-title":"Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses","volume":"77","author":"Sarobe","year":"2003","journal-title":"J. Virol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1128\/JVI.02547-07","article-title":"Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production","volume":"82","author":"Saito","year":"2008","journal-title":"J. Virol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Vincent, I.E., Zannetti, C., Lucifora, J., Norder, H., Protzer, U., Hainaut, P., Zoulim, F., Tommasino, M., Trepo, C., and Hasan, U. (2011). Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026315"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.chom.2012.08.010","article-title":"Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity","volume":"12","author":"Dreux","year":"2012","journal-title":"Cell Host Microbe."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ni.2647","article-title":"Exosomes mediate the cell-to-cell transmission of IFN-alpha-induced antiviral activity","volume":"14","author":"Li","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/cmi.12339","article-title":"IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection","volume":"17","author":"Zhu","year":"2015","journal-title":"Cell Microbiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/cmi.2016.24","article-title":"Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction","volume":"14","author":"Yang","year":"2017","journal-title":"Cell Mol. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1128\/JVI.02721-14","article-title":"Virion-independent transfer of replication-competent hepatitis C virus RNA between permissive cells","volume":"89","author":"Longatti","year":"2015","journal-title":"J. Virol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2013.10.015","article-title":"HCV transmission by hepatic exosomes establishes a productive infection","volume":"60","author":"Cosset","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Bukong, T.N., Momen-Heravi, F., Kodys, K., Bala, S., and Szabo, G. (2014). Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with ago2-miR122-HSP90. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004424"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1096\/fj.201600696R","article-title":"Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes","volume":"30","author":"Zhou","year":"2016","journal-title":"FASEB J."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.aab3632","article-title":"Viruses transfer the antiviral second messenger cgamp between cells","volume":"349","author":"Bridgeman","year":"2015","journal-title":"Science"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.coi.2016.09.005","article-title":"T cell exhaustion and immune-mediated disease-the potential for therapeutic exhaustion","volume":"43","author":"McKinney","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2014.07.005","article-title":"Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation","volume":"61","author":"Bengsch","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Tzeng, H.T., Tsai, H.F., Liao, H.J., Lin, Y.J., Chen, L., Chen, P.J., and Hsu, P.N. (2012). PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039179"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Fisicaro, P., Valdatta, C., Massari, M., Loggi, E., Biasini, E., Sacchelli, L., Cavallo, M.C., Silini, E.M., Andreone, P., and Missale, G. (2010). Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology.","DOI":"10.1053\/j.gastro.2009.09.052"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.4049\/jimmunol.178.5.2714","article-title":"PD-1:PD-l1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver","volume":"178","author":"Maier","year":"2007","journal-title":"J. Immunol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/JVI.79.6.3322-3328.2005","article-title":"Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection","volume":"79","author":"Franzese","year":"2005","journal-title":"J. Virol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.3748\/wjg.v12.i27.4310","article-title":"Mechanism of T cell hyporesponsiveness to hbcag is associated with regulatory T cells in chronic hepatitis B","volume":"12","author":"Kondo","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.20649","article-title":"Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection","volume":"41","author":"Stoop","year":"2005","journal-title":"Hepatology"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.virol.2006.11.018","article-title":"Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B","volume":"361","author":"Stoop","year":"2007","journal-title":"Virology"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/653496","article-title":"Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes","volume":"202","author":"Kondo","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_155","first-page":"1437","article-title":"Suppression of HCV-specific t cells without differential hierarchy demonstrated ex vivo in persistent HCV infection","volume":"38","author":"Sugimoto","year":"2003","journal-title":"Hepatology"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20162115","article-title":"IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection","volume":"214","author":"Pallett","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"De Jong, Y.P., Dorner, M., Mommersteeg, M.C., Xiao, J.W., Balazs, A.B., Robbins, J.B., Winer, B.Y., Gerges, S., Vega, K., and Labitt, R.N. (2014). Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Sci. Transl. Med.","DOI":"10.1126\/scitranslmed.3009512"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.inf.0000050463.28917.25","article-title":"Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination","volume":"22","author":"Williams","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2147\/PPA.S49776","article-title":"Antibody and immune memory persistence post infant hepatitis B vaccination","volume":"7","author":"Hudu","year":"2013","journal-title":"Patient Preference Adherence"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Ciupe, S.M., Ribeiro, R.M., and Perelson, A.S. (2014). Antibody responses during hepatitis B viral infection. PLoS Comput. Biol., 10.","DOI":"10.1371\/journal.pcbi.1003730"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e29282","DOI":"10.5812\/hepatmon.29282","article-title":"HCV dsRNA-activated macrophages inhibit HCV replication in hepatocytes","volume":"15","author":"Wang","year":"2015","journal-title":"Hepat. Mon."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2014.11.007","article-title":"MDA5 plays a critical role in interferon response during hepatitis C virus infection","volume":"62","author":"Cao","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4a protease-mediated cleavage of the toll-like receptor 3 adaptor protein TRIF","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"17717","DOI":"10.1073\/pnas.0508531102","article-title":"Hepatitis C virus protease NS3\/4a cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.4049\/jimmunol.1301459","article-title":"IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection","volume":"192","author":"Okamoto","year":"2014","journal-title":"J. Immunol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"15417","DOI":"10.1128\/JVI.79.24.15417-15429.2005","article-title":"SOCS1 and SOCS3 are targeted by hepatitis C virus core\/GC1qr ligation to inhibit T-cell function","volume":"79","author":"Yao","year":"2005","journal-title":"J. Virol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jhep.2013.03.019","article-title":"Hepatitis C virus NS4b blocks the interaction of sting and TBK1 to evade host innate immunity","volume":"59","author":"Ding","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Neufeldt, C.J., Joyce, M.A., Van Buuren, N., Levin, A., Kirkegaard, K., Gale, M., Tyrrell, D.L., and Wozniak, R.W. (2016). The hepatitis C virus-induced membranous web and associated nuclear transport machinery limit access of pattern recognition receptors to viral replication sites. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005428"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1017\/S1355838202020617","article-title":"Activation and evasion of the antiviral 2\u2032-5\u2032 oligoadenylate synthetase\/ribonuclease l pathway by hepatitis C virus mRNA","volume":"8","author":"Han","year":"2002","journal-title":"RNA"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Tsutsumi, T., Okushin, K., Enooku, K., Fujinaga, H., Moriya, K., Yotsuyanagi, H., Aizaki, H., Suzuki, T., Matsuura, Y., and Koike, K. (2017). Nonstructural 5a protein of hepatitis C virus interferes with toll-like receptor signaling and suppresses the interferon response in mouse liver. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170461"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.285.5424.107","article-title":"Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein","volume":"285","author":"Taylor","year":"1999","journal-title":"Science"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coviro.2016.09.004","article-title":"Viral evasion and challenges of hepatitis C virus vaccine development","volume":"20","author":"Pierce","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4254\/wjh.v7.i6.831","article-title":"Hepatitis C virus genetic variability and evolution","volume":"7","author":"Echeverria","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s15010-008-8197-6","article-title":"Virological and epitope evolution of HCV infection from acute hepatitis C to subsequent episodes of HCV-related acute liver cell necrosis","volume":"37","author":"Sagnelli","year":"2009","journal-title":"Infection"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.22379","article-title":"Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection","volume":"48","author":"Neveu","year":"2008","journal-title":"Hepatology"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/vim.2006.19.458","article-title":"Immunogenic variation between multiple HLA-A*0201-restricted, hepatitis C virus-derived epitopes for cytotoxic T lymphocytes","volume":"19","author":"Ohno","year":"2006","journal-title":"Viral. Immunol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1128\/JVI.00577-15","article-title":"Apolipoprotein E, but not apolipoprotein B, is essential for efficient cell-to-cell transmission of hepatitis C virus","volume":"89","author":"Gondar","year":"2015","journal-title":"J. Virol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.jmb.2013.02.025","article-title":"Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies","volume":"425","author":"Pantua","year":"2013","journal-title":"J. Mol. Biol."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Bankwitz, D., Doepke, M., Hueging, K., Weller, R., Bruening, J., Behrendt, P., Lee, J.Y., Vondran, F.W.R., Manns, M.P., and Bartenschlager, R. (2017). Maturation of secreted HCV particles by incorporation of secreted apoe protects from antibodies by enhancing infectivity. J. Hepatol.","DOI":"10.1016\/j.jhep.2017.04.010"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Khan, M., Syed, G.H., Kim, S.J., and Siddiqui, A. (2016). Hepatitis B virus-induced parkin-dependent recruitment of linear ubiquitin assembly complex (LUBAC) to mitochondria and attenuation of innate immunity. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005693"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.4049\/jimmunol.1201625","article-title":"Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes\/macrophages by interfering with JNK activation","volume":"190","author":"Wang","year":"2013","journal-title":"J. Immunol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.26064","article-title":"Hepatitis B virus polymerase impairs interferon-alpha-induced STAT activation through inhibition of importin-alpha5 and protein kinase C-delta","volume":"57","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jhep.2014.11.035","article-title":"Human hepatitis B virus surface and E antigens inhibit major vault protein signaling in interferon induction pathways","volume":"62","author":"Liu","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"21840","DOI":"10.18632\/oncotarget.4808","article-title":"Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy","volume":"6","author":"Miyakawa","year":"2015","journal-title":"Oncotarget"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Wang, H., and Ryu, W.S. (2010). Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: Implications for immune evasion. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000986"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1128\/JVI.02760-14","article-title":"Hepatitis B virus polymerase disrupts k63-linked ubiquitination of sting to block innate cytosolic DNA-sensing pathways","volume":"89","author":"Liu","year":"2015","journal-title":"J. Virol."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Liu, D., Wu, A., Cui, L., Hao, R., Wang, Y., He, J., and Guo, D. (2014). Hepatitis B virus polymerase suppresses nf-kappab signaling by inhibiting the activity of IKKs via interaction with HSP90beta. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091658"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/cmi.2017.1","article-title":"Inducible rubicon facilitates viral replication by antagonizing interferon production","volume":"14","author":"Wan","year":"2017","journal-title":"Cell Mol. Immunol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s13238-010-0141-8","article-title":"Mechanism of inhibiting type i interferon induction by hepatitis B virus x protein","volume":"1","author":"Jiang","year":"2010","journal-title":"Protein Cell"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Niu, C., Livingston, C.M., Li, L., Beran, R.K., Daffis, S., Ramakrishnan, D., Burdette, D., Peiser, L., Salas, E., and Ramos, H. (2017). The SMC5\/6 complex restricts hbv when localized to ND10 without inducing an innate immune response and is counteracted by the HBV x protein shortly after infection. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169648"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Lim, K.H., Park, E.S., Kim, D.H., Cho, K.C., Kim, K.P., Park, Y.K., Ahn, S.H., Park, S.H., Kim, K.H., and Kim, C.W. (2017). Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5\u2032-UTR of TRIM22. Gut.","DOI":"10.1136\/gutjnl-2016-312742"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1099\/vir.0.18966-0","article-title":"Hepatitis B virus downregulates the human interferon-inducible mxa promoter through direct interaction of precore\/core proteins","volume":"84","author":"Fernandez","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01703079","article-title":"Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell","volume":"8","author":"Bock","year":"1994","journal-title":"Virus Genes"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3851\/IMP1619","article-title":"Molecular genetics of HBV infection","volume":"15","author":"Locarnini","year":"2010","journal-title":"Antivir. Ther."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4161\/epi.6.6.15815","article-title":"HBC binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state","volume":"6","author":"Guo","year":"2011","journal-title":"Epigenetics"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBX binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"Hbx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccdna involving setdb1 histone methyltransferase","volume":"63","author":"Riviere","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Meier, M.A., Suslov, A., Ketterer, S., Heim, M.H., and Wieland, S.F. (2017). Hepatitis B virus covalently closed circular DNA homeostasis is independent of the lymphotoxin pathway during chronic HBV infection. J. Viral. Hepat.","DOI":"10.1111\/jvh.12689"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1016\/j.jmb.2016.05.022","article-title":"APOBEC3de antagonizes hepatitis B virus restriction factors APOBEC3f and APOBEC3g","volume":"428","author":"Bouzidi","year":"2016","journal-title":"J. Mol. Biol."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Vartanian, J.P., Henry, M., Marchio, A., Suspene, R., Aynaud, M.M., Guetard, D., Cervantes-Gonzalez, M., Battiston, C., Mazzaferro, V., and Pineau, P. (2010). Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000928"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1099\/vir.0.83507-0","article-title":"Hypermutation of hepatitis B virus genomes by APOBEC3g, APOBEC3c and APOBEC3h","volume":"89","author":"Kock","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21733","article-title":"Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3c","volume":"46","author":"Baumert","year":"2007","journal-title":"Hepatology"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/JVI.02510-06","article-title":"Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3g","volume":"81","author":"Nguyen","year":"2007","journal-title":"J. Virol."},{"key":"ref_206","first-page":"3165","article-title":"Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2","volume":"175","author":"Cooper","year":"2005","journal-title":"J. Immuno.l"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbrc.2011.12.138","article-title":"Human hepatitis B viral e antigen and its precursor p20 inhibit T lymphocyte proliferation","volume":"417","author":"Purvina","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","article-title":"Maternal-derived hepatitis B virus E antigen alters macrophage function in offspring to drive viral persistence after vertical transmission","volume":"44","author":"Tian","year":"2016","journal-title":"Immunity"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Peppa, D., Micco, L., Javaid, A., Kennedy, P.T., Schurich, A., Dunn, C., Pallant, C., Ellis, G., Khanna, P., and Dusheiko, G. (2010). Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001227"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhep.2010.07.009","article-title":"Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B","volume":"54","author":"Tjwa","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Oliviero, B., Varchetta, S., Paudice, E., Michelone, G., Zaramella, M., Mavilio, D., De Filippi, F., Bruno, S., and Mondelli, M.U. (2009). Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology.","DOI":"10.1053\/j.gastro.2009.05.047"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jhep.2009.12.005","article-title":"T cell immunoglobulin- and mucin-domain-containing molecule-3 (TIM-3) mediates natural killer cell suppression in chronic hepatitis B","volume":"52","author":"Ju","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2009.05.030","article-title":"Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C","volume":"51","author":"Bonorino","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1038\/emi.2013.10","article-title":"Hepatitis B virus genetic variants: Biological properties and clinical implications","volume":"2","author":"Tong","year":"2013","journal-title":"Emerg. Microbes. Infect."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0168-8278(03)00152-1","article-title":"Hepatitis B vaccines","volume":"39","author":"Shouval","year":"2003","journal-title":"J. Hepatol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/02724936.1997.11747902","article-title":"Long-term antibody persistence after booster vaccination with combined tetravalent diphtheria tetanus, whole-cell bordetella pertussis and hepatitis B vaccine in healthy infants","volume":"17","author":"Poovorawan","year":"1997","journal-title":"Ann. Trop. Paediatr."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/0264-410X(94)90178-3","article-title":"Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): Phase 1, 2 and 3 clinical testing","volume":"12","author":"Suzuki","year":"1994","journal-title":"Vaccine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/5\/3\/24\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:43:51Z","timestamp":1760208231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/5\/3\/24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":217,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,9]]}},"alternative-id":["vaccines5030024"],"URL":"https:\/\/doi.org\/10.3390\/vaccines5030024","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,1]]}}}